Data / Drug companies / Basf Corporation
Basf Corporation: 17 products in the FDA NDC directory, labeler code 10117
Basf Corporation (labeler code 10117) lists 17 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients, 2 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on May 1, 2022.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 10117
- Products in commercial distribution
- 17
- Packages
- 21
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 1, 1980
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 13 | 76.5% |
| Bulk ingredients for compounding | 2 | 11.8% |
| Drugs for further processing | 2 | 11.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 88.2% |
| Drugs for further processing | 2 | 11.8% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 14 | 82.4% |
| Liquid | 3 | 17.6% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Zinc oxide | 10117-3011 | Powder | Bulk ingredients | May 1, 2022 |
| Zinc oxide | 10117-3010 | Powder | Bulk ingredients | May 6, 2019 |
| Zinc oxide | 10117-3009 | Powder | Drugs for further processing | March 31, 2019 |
| Zinc oxide | 10117-3008 | Powder | Bulk ingredients | May 12, 2014 |
| Ibuprofen dc85w | 10117-0931 | Powder | Bulk ingredients | January 2, 2014 |
| Zinc oxide | 10117-3006 | Powder | Bulk ingredients | August 12, 2013 |
| Zinc oxide | 10117-3007 | Powder | Bulk ingredients | May 11, 2012 |
| Ibuprofen | 10117-0952 | Powder | Bulk ingredients | June 8, 2010 |
| Ibuprofen | 10117-0936 | Powder | Bulk ingredients for compounding | June 8, 2010 |
| Ibuprofen | 10117-0930 | Powder | Bulk ingredients for compounding | June 8, 2010 |
| Ibuprofen | 10117-0926 | Powder | Bulk ingredients | June 8, 2010 |
| Sodium ibuprofen dihydrate | 10117-0990 | Powder | Bulk ingredients | April 1, 2005 |
| Octinoxate, avobenzone | 10117-3613 | Liquid | Drugs for further processing | January 14, 2005 |
| Zinc oxide | 10117-3004 | Powder | Bulk ingredients | May 25, 2000 |
| Zinc oxide | 10117-3003 | Powder | Bulk ingredients | May 25, 2000 |
| Poloxalene | 10117-2019 | Liquid | Bulk ingredients | January 1, 1980 |
| Poloxalene | 10117-0218 | Liquid | Bulk ingredients | January 1, 1980 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.